Neuroscience

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with…

3 months ago

From Geneva to Tokyo: World Meditation League Launches Quantified Meditation Challenge

GENEVA, Sept. 18, 2025 /PRNewswire/ -- Following the landmark Geneva Meditation Challenge in June, the World Meditation League (WML), in partnership with All…

3 months ago

Linus Health’s AI-Driven Voice Analysis Technology Recognized in Gartner® Hype Cycle™ for Digital Care Delivery, 2025

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and…

3 months ago

ALLT.AI unveils the next generation of Large Language Models (LLMs) driven by the remarkable power and efficiency of the human brain

Translating decades of clinical neuroscience research into next-generation AI—ALLT.AI harnesses key data from damaged brains to create radically more efficient…

3 months ago

Aoki Games & Gala 2025 Returns to Las Vegas Sunday, September 21

Live performance, visionary conversations, and a tribute to Ray Kurzweil unite in support of brain health and innovation. LAS VEGAS,…

3 months ago

ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair

– Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of…

3 months ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) servicesMALVERN, Pa., Sept. 17, 2025…

3 months ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to…

3 months ago

Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025

Six poster presentations showcase clinical and real-world data in major depressive disorder, Alzheimer’s disease agitation, narcolepsy, and obstructive sleep apneaNEW…

3 months ago

MedRhythms and Edwards Health Care Services, a GEMCORE Family Company, Enter into National Distribution Agreement

This partnership enables nationwide access to InTandem® for adults with chronic stroke and MOVIVE™ for people with Parkinson's disease (PD) PORTLAND, Maine,…

3 months ago